Effect of parecoxib on postoperative pain after lumbar spine surgery: A bicenter, randomized, double-blinded, placebo-controlled trial

Spine

Volumn 33, Issue 2, 2008, Pages 132-139

  Jirarattanaphochai, Kitti ^a   Thienthong, Somboon ^a   Sriraj, Wimonrat ^a   Jung, Surachai ^a   Pulnitiporn, Aksorn ^b   Lertsinudom, Somkid ^b   Foocharoen, Thanit ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN HOSPITAL   (Thailand)

Author keywords

Cyclooxygenase 2 inhibitors; Lumbar spine surgery; Nonsteroidal anti inflammatory drugs; Parecoxib; Postoperative pain; Randomized controlled trial

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; MORPHINE; PARECOXIB;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FEMALE; HUMAN; HYPOTENSION; INTERVERTEBRAL DISKECTOMY; MAJOR CLINICAL STUDY; MALE; PAIN THRESHOLD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; SINGLE BLIND PROCEDURE; SPINAL CORD DECOMPRESSION; SPINE FUSION; SPINE SURGERY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; CYCLOOXYGENASE INHIBITORS; DECOMPRESSION, SURGICAL; DISKECTOMY; DRUG THERAPY, COMBINATION; HUMANS; ISOXAZOLES; LUMBAR VERTEBRAE; MIDDLE AGED; MORPHINE; ORTHOPEDIC PROCEDURES; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; SPINAL FUSION; TREATMENT OUTCOME;

EID: 38149007218     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181604529     Document Type: Article

References (55)

1. Marret E, Kurdi O, Zufferrey P, et al. Effect of nonsteroidal anti-inflammatory drugs on patients controlled analgesia morphine side effects. Anesthesiology 2005;102:1249-60.
2. Kehlet H, Dahl JB. The value of multimodal or balanced analgesia in postoperative pain treatment. Anesth Analg 1993;77:1048-56.
3. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg 2002;25:6-21.
4. Acute Pain Management Guideline Panel. Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Service, Public Health Service, Agency for Health Care Policy and Research, Public Health Service; February 15-26, 1992. AHPCR Pub. No. 92-0032.
5. Cashman J, Mcanulty G. Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimal use. Drugs 1995;49:51-70.
6. Moniche S, Romsing J, Dahl JB, et al. Nonsteroidal anti-inflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 2003;96:68-77.
7. Chen LC, Elliott RA, Ashcroft DM. Systematic review of the analgesic effi-cacy and tolerability of COX-2 inhibitors in post-operative pain control. J Clin Pharm Ther 2004;29:215-29.
8. Cicconetti A, Bartoli A, Ripari F, et al. Cox-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:139-46.
9. Gajraj NM, Joshi GP. Role of cyclooxygenase-2 inhibitors in postoperative pain management. Anesthesiol Clin North America 2005;23:49-72.
10. Romsing J, Moiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for postoperative pain. Acta Anesthesiol Scand 2004;48:525-46.
11. Straube S, Derry S, McQuay HJ, et al. Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies. Acta Anaesthesiol Scand 2005;601-13.
12. Leese PT, Hubbard RC, Karim A, et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 2000;40:124-32.
13. Noveck RJ, Laurent A, Kuss M, et al. Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals. Clin Drug Invest 2001;21:465-76.
14. Joshi W, Connelly NR, Reuben SS, et al. An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management. Anesth Analg 2003;97:35-8.
15. Schulze S. Humoral and neural mediators of the systematic response to surgery. Dan Med Bull 1993;40:365-77.
16. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-5.
17. Reuben SS, Buvenandrean A, Kroin JS, et al. Effect of cyclooxygenase inhibitors on cerebrospinalfluid (CSF) prostaglandin E2 (PGE2) after surgery. Anesthesiology 2005;103:A1476.
18. Desjardins PJ, Traylor L, Hubbard RC. Analgesic efficacy of preoperative parecoxib sodium in an orthopedic pain model. J Am Podiatr Med Assoc 2004;94:305-14.
19. Gan TJ, Joshi GP, Zhao SZ, et al. Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. Acta Anaesthesiol Scand 2004;48:1194-207.
20. Joshi GP, Viscusi ER, Gan TJ, et al. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. Anesth Analg 2004;98:336-42.
21. Khalil MW, Chaterjee A, Macbryde G, et al. Single dose parecoxib significantly improves ventilatory function in early extraction coronary artery bypass surgery: a prospective randomized double blind placebo controlled trial. Br J Anesth 2006;96:171-8.
22. Kranke P, Morin AM, Roewer N, et al. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: a quantitative systematic review. Anesth Analg 2004;99:797-806.
23. Malan TP Jr, Gordon S, Hubbard R, et al. The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery. Anesth Analg 2005;100:454-60.
24. Mehlisch DR, Desjardins PJ, Daniels S, et al. The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain. J Am Dent Assoc 2004;135:1578-90.
25. Ng A, Temple A, Smith G, et al. Early analgesic effects of parecoxib versus ketorolac following laparoscopic sterilization: a randomized controlled trial. Br J Anaesth 2004;92:846-9.
26. Nussmeier NA, Whelton AA, Brown MT, et al. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology 2006;104:518-26.
27. Gorman DJ, Kam PA, Brisby H, et al. When is spinal pain neuropathic? Orthop Clin North Am 2004;35:73-84.
28. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
29. Reuben SS, Buvanendran A, Kroin JS, et al. The analgesic efficacy of celecoxib, pregabalin, and their combination for spinal fusion surgery. Anesth Analg 2006;103:1271-7.
30. Reuben SS, Ekman EF. The effect of cyclooxygenase-2 inhibitions on analgesia and spinal fusion. J Bone Joint Surg Am 2005;87:536-42.
31. Reuben SS, Connelly NR. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 2000;91:1221-5.
32. Bekker A, Cooper PR, Frempong-Boadu A, et al. Evaluation of preoperative administration of the cyclooxygenase-2 inhibitor rofecoxib for the treatment of postoperative pain after lumbar disc surgery. Neurosurgery 2002;50:1053-8.
33. Grunmann U, Wornle C, Biedler A, et al. The efficacy of the non opioid analgesic parecoxib, paracetamol and metamizol for postoperative pain relief after lumbar microdisectomy. Anesth Analg 2006;103:217-22.
34. Karst M, Kegel T, Lukas A, et al. Effect of celecoxib and dexamethasone on postoperative pain after lumbar disc surgery. Neurosurgery 2003;53:331-7.
35. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports or parallel-group trials. Lancet 2001;357:1191-4.
36. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
37. Tverskoy M, Oren M, Dakovsky I, et al. Alfentanil dose response relationships for relief of postoperative pain. Anesth Analg 1996;83:387-93.
38. Gilron I, Milne B, Hong M. Cyclooxygenase-2 inhibitors inj postoperative management. Current evidence and future directions. Anesthesiology 2003;99:1198-208.
39. Barden J, Edwards JE, McQuay HJ, et al. Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol 2003;3:1-8.
40. Jain KK. Evaluation of intravenous parecoxib for the relief of acute post surgical pain. Expert Opin Investig Drugs 2000;9:2717-23.
41. Amabile CM, Spencer AP. Parecoxib for parenteral analgesia in postsurgical patients. Ann Pharmacother 2004;38:882-6.
42. Beiche F, Scheuerer S, Brune K, et al. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 1996;390:165-9.
43. Kroin JS, Ling ZD, Buvanendran A, et al. Up regulation of spinal cyclooxygenase-2 in rats after surgical incision. Anesthesiology 2004;100:364-9.
44. Schafer A. Effects of nonsteroidal anti-inflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995;35:209-19.
45. Leese PT, Talwalker S, Kent JD, et al. Valdecoxib does not impair platelet function. Am J Emerg Med 2002;20:275-81.
46. Leese PT, Recker DP Kent JD. The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial. J Clin Pharmacol 2003;43:504-13.
47. Pickering AE, Bridge HS, Nolan J, et al. Double-blind, placebo-controlled analgesic study of ibuprofen or rofecoxib in combination with paracetamol for tonsillectomy in children. Br J Anaesth 2002;88:72-7.
48. Marret E, Flahault A, Samama CM, et al. Effect of postoperative nonsteroidal anti-inflammatory drugs on bleeding risk after tonsillectomy. Anesthesilogy 2003;98:1497-502.
49. Maxy R, Glassman S. The effect of nonsteroidal anti-inflammatory drugs on osteogenesis and spinal fusion. Reg Anesth Pain Med 2001;26:156-8.
50. Deguchi M, Rapoff A, Zdeblick T. Postterolateral fusion for isthmic spondylolisthesis in adults: a study of fusion rate and clinical results. J Spinal Disord 1998;11:459-64.
51. Long J, Lewis S, Kuklo T, et al. The effect of cyclooxygenase-2 inhibitors on spinal fusion. J Bone Joint Surg Am 2002;84:1763-8.
52. Reuben SS, Ablett D, Kaye R. High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Can J Anaesth 2005;52:506-12.
53. Barton SF, Langeland FF, Snabes MC, et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology 2002;97:306-14.
54. Malan TP Jr, Marsh G, Hakki SI, et al. Parecoxib sodium, a parenteral cyclooxygenase-2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology 2003;98:950-6.
55. Riest G, Peter J, Weiss M, et al. Does perioperative administration of rofecoxib improve analgesia after spine, breast and orthopaedic surgery? Eur J Anesthesiol 2006;23:219-26.